Science and Research

Microbiome-Targeted Antibiotics Provide No Additional Microbiologic or Inflammatory Benefit during Cystic Fibrosis Pulmonary Exacerbations: Results from the CFMATTERS Trial

  • Einarsson, G. G.
  • Lee, A. J.
  • Alfahl, Z.
  • Kerrigan, L.
  • Eustace, J. A.
  • Weldon, S.
  • Plant, B. J.
  • Elborn, J. S.
  • Taggart, C. C.
  • Mall, M. A.
  • Tunney, M. M.
Publication details
DOI: 10.1093/ajrccm/aamag336
Journal: Am J Respir Crit Care Med
Work Type: Original
Location: Assoziierter Partner
Disease Area: CFBE
Partner / Member: BIH
Access-Number: 42371757
See publication on PubMed


chevron-down